Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Hypersensitivity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02395133
What this trial is testing

Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 422
Large-scale testing (Phase 3)Study completedNCT03160885
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)

Who this might be right for
Atopic Dermatitis
LEO Pharma 794
Early research (Phase 1)Study completedNCT04271514
What this trial is testing

A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
RAPT Therapeutics, Inc., a member of the GSK plc group of companies 103
Not applicableStudy completedNCT07017348
What this trial is testing

Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic Dermatitis

Who this might be right for
Atopic DermatitisHealthy
Pierre Fabre Dermo Cosmetique 50
Early research (Phase 1)Study completedNCT01405963
What this trial is testing

Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma

Who this might be right for
Asthma
Amgen 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT07762833
What this trial is testing

Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Galderma R&D 240
Testing effectiveness (Phase 2)Study completedNCT01098734
What this trial is testing

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Who this might be right for
Dermatitis, Atopic
Welichem Biotech Inc. 148
Large-scale testing (Phase 3)Not Yet RecruitingNCT07377838
What this trial is testing

Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
EHL Bio Co., Ltd. 286
Testing effectiveness (Phase 2)Study completedNCT05014438
What this trial is testing

BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Bristol-Myers Squibb 17
Not applicableStudy completedNCT02594969
What this trial is testing

The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
University of California, Davis 20
Not applicableLooking for participantsNCT05721937
What this trial is testing

How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

Who this might be right for
Atopic Dermatitis
Pfizer 400
Not applicableUnknownNCT03872219
What this trial is testing

Biodiversity Intervention and Atopic Sensitization

Who this might be right for
AtopyAllergyAllergic Rhinitis+1 more
University of Helsinki 350
Not applicableStudy completedNCT03918772
What this trial is testing

Clinical Determinants and Perioperative Allergic Reactions (CADECAP Study)

Who this might be right for
Hypersensitivity, ImmediatePerioperative Period
Assistance Publique - Hôpitaux de Paris 145
Testing effectiveness (Phase 2)Ended earlyNCT03055195
What this trial is testing

Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 34
Not applicableStudy completedNCT00929981
What this trial is testing

Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients

Who this might be right for
Dermatitis, Contact
Pfizer 80
Not applicableStudy completedNCT01295866
What this trial is testing

Evaluation Effects of Nasal Nitric Oxide Measurements Are Associated With Atopy Status in Chronic Nasal Inflammation

Who this might be right for
HypersensitivityRhinitisRespiratory Tract Diseases+2 more
Beijing Tongren Hospital 131
Not applicableLooking for participantsNCT05689151
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic DermatitisEczema
Pfizer 183
Testing effectiveness (Phase 2)Study completedNCT05158023
What this trial is testing

Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
ASLAN Pharmaceuticals 302
Testing effectiveness (Phase 2)Study completedNCT05432596
What this trial is testing

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 250
Not applicableNot Yet RecruitingNCT04730024
What this trial is testing

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 102
Next Page